The S&P 500 shed 29.43 points, the Dow Jones Industrial Average declined 105.07 points, while the Nasdaq composite dropped 243.82 points
U.S. stock indexes pulled back from their recent record highs Wednesday, as virus cases surge and coronavirus vaccines move closer to distribution.
The S&P 500 index fell 0.8%, as losses in technology companies outweighed gains in industrial, energy and materials stocks. The benchmark index is still up 1.4% for the month after climbing to record highs four times in the past two weeks.
Markets have been mostly pushing higher in recent weeks on hopes that one or more coronvairus vaccines will begin to be distributed in coming weeks and begin to ease the economy out of the pandemic’s grip.
A vaccine from Pfizer and German partner BioNTech, which is already in use in the U.K., is on track for a positive review and potential approval in the U.S. within the next week. The Food and Drug Administration will also consider a vaccine developed by Moderna later this month.
But there could be more economic damage in store over the next few months and investors are still closely watching Washington for any developments on another shot of stimulus for people, businesses and state governments. Congress is still divided over the size and scope of any new package and the Trump administration has added to the potential plans with a new $916 billion proposal.
You haven’t seen a deal out of Congress, so to the extent that markets have been rallying on another round of hope about stimulus, not getting that lets a little bit of air out of the market, said Willie Delwiche, investment strategist at Baird.
The S&P 500 dropped 29.43 points to 3,672.82. The Dow Jones Industrial Average lost 105.07 points, or 0.4%, to 30,068.81. The tech-heavy Nasdaq composite fell 243.82 points, or 1.9%, to 12,338.95.
Technology stocks fell and dragged much of the market with them. Health care and communications stocks also slipped. Microsoft shed 1.9% while Pfizer Inc. fell 1.7%.
About 56% of the companies in the S&P 500 fell, led by Qorvo, which declined 5.6%.
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.